ALLERGIC DISEASE
Clinical trials for ALLERGIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC DISEASE trials appear
Sign up with your email to follow new studies for ALLERGIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy drug Exl-111 enters first human tests
Symptom relief Recruiting nowThis early-stage trial tests the safety of a new drug called Exl-111 for allergic diseases. It involves 70 healthy adults aged 18-55. Participants receive either the drug, a placebo, or an active comparator (omalizumab) to see how the body handles it and if any side effects occur…
Matched conditions: ALLERGIC DISEASE
Phase: PHASE1 • Sponsor: Excellergy Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC
-
Could a simple cord blood test predict eczema in babies?
Knowledge-focused Recruiting nowThis study examines whether newborns with a family history of allergies have self-reactive antibodies in their cord blood that may predict eczema. Researchers will follow 500 babies for two years, checking their skin and antibody levels at birth, 6, 12, and 24 months. The goal is…
Matched conditions: ALLERGIC DISEASE
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated May 17, 2026 07:06 UTC